Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2007
10/11/2007DE60022050C5 Metabotrope glutamatrezeptorantagonisten zur behandlung von krankheiten des zentralen nervensystems Metabotropic glutamate receptor antagonists for treating diseases of the central nervous system
10/11/2007CA2648003A1 Orally bioavailable caffeic acid related anticancer drugs
10/11/2007CA2647811A1 Substituted bicyclic derivative and use thereof
10/11/2007CA2647616A1 Process for preparing 6,7-dihydro-5h-imidazo[1,5-a]pyridin-8-one
10/11/2007CA2647445A1 N-hydroxy-3-(4-{3-phenyl-s-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds as histone deacetylase inhibitors for the treatment of cancer
10/11/2007CA2643597A1 Glyceride ester derivatives of herbicidal compounds and compositions thereof
10/11/2007CA2629321A1 Glucagon receptor antagonists, preparation and therapeutic uses
10/10/2007EP1842847A1 Process for production of 5-chloro-2,4-dihydroxypyridine
10/10/2007EP1841767A1 Pyrazolopyridines, their preparation and their medical use
10/10/2007EP1841756A1 3-heterocyclyl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
10/10/2007EP1841743A1 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
10/10/2007EP1841742A1 3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
10/10/2007EP1841739A1 Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon2-yl)methyl] piperidine or its salt thereof via novel intermediate
10/10/2007EP1841504A2 Substituted biaryl compounds as factor xia inhibitors
10/10/2007EP1841436A1 Compounds and methods for regulating triglyceride levels
10/10/2007EP1756119B1 Collection of traceable compounds and uses thereof
10/10/2007EP1756029B1 Novel compounds, the preparation and the use thereof for a regiospesific synthesis of perfluor(alkyl) group heterocycles
10/10/2007EP1610792B1 Calcium channel blockers comprising two benzhydril moieties
10/10/2007EP1442019B1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
10/10/2007EP1379525B1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/10/2007EP1332132B1 Enamine derivatives as cell adhesion molecules
10/10/2007EP1232150B1 Urea derivatives as anti-inflammatory agents
10/10/2007CN101052634A Anthranilamide pyridinureas as vegf receptor kinase inhibitors
10/10/2007CN101052627A Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
10/10/2007CN101052625A Adamantyl derivates as p2x7 receptor antagonists
10/10/2007CN101052620A Benzamide compound
10/10/2007CN101052619A Process for the preparation of 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenyoxy}n-methylpyridine-2-carboxamide
10/10/2007CN101052603A Aryl, olefine and acetylene hydrocarbon catalyticed by iron or cobalt and copper reagent c-c bond crossoupling reaction
10/10/2007CN101052398A N-(pyridin-3-yl)-2-phenylbutanamides as androgen receptor modulators
10/10/2007CN101052301A (hetero) cyclylcarboxamide for preventing and controlling pathogenic fungi
10/10/2007CN101050201A N - (3 - methyl pyridine - 2) 2,2,2 ¿C trifloro-acetyl imine acyl chloride, and preparation method
10/10/2007CN100341854C Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
10/10/2007CN100341408C Pyrithione biocides enhanced by silver, copper, or zinc ions
10/09/2007US7279593 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
10/09/2007US7279578 Use as orexin receptor antagonists, depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis; depressive neurosis; anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; schizophrenia; manic depression; delerium
10/09/2007US7279493 cyanoiminopiperazines which inhibit vanilloid receptor 1 function in a cell
10/09/2007US7279492 Photostability; enhanced pharmacological activity
10/09/2007US7279478 Cathepsin cysteine protease inhibitors
10/09/2007US7279477 Cardiovascular disease, diabetes, acidosis, cancer, obesity; such as 1-butyl-3,3-dimethyl-1-(4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl -ethyl)-phenyl)-thiourea
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279444 for controlling undesirable plants
10/09/2007US7279314 Chemical substance having morphogenetic and growth-accelerating activities
10/04/2007WO2007112299A2 Enzymatic preparation of (s) amino acid from (r,s) amino acid or from keto acid
10/04/2007WO2007111921A1 1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases
10/04/2007WO2007110337A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/04/2007WO2007072201A3 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
10/04/2007WO2007060215A3 (r)-arylkylamino derivatives and pharmaceutical compositions containing them
10/04/2007WO2007049158A3 Ppar modulating biaromatic compounds
10/04/2007WO2007035489A3 Methods of treating or preventing cancer using pyridine carboxaldehyde pyridine thiosemicarbazone radiosensitizing agents
10/04/2007WO2007007207A8 Pharmaceutical compositions of 3, 5 -bis (arylidene) -4 -piperidones and analogues there of for modulating cell proliferation
10/04/2007US20070232837 Process for the Production of Cyclic Diketones
10/04/2007US20070232807 catalytic carboxylation of 3-methylpyridine to form nicotinic acid in presence of manganese bromide and in an aqueous solvent under supercritical conditions
10/04/2007US20070232668 Orally Bioavailable Caffeic Acid Related Anticancer Drugs
10/04/2007US20070232655 2-Pyridinylcycloalkylcarboxamide Derivatives Useful as Fungicides
10/04/2007US20070232654 Novel Compounds and Compositions as Cathepsin Inhibitors
10/04/2007US20070232651 Novel anabaseine derivatives, pharmaceutical compositions and methods of use thereof
10/04/2007US20070232635 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
10/04/2007US20070232621 Linear dicationic terphenyls and their aza analogues as antiparasitic agents
10/04/2007US20070232614 Therapeutic Agent for Nonviral Hepatitis
10/04/2007US20070231858 Enzymatic preparation of (s) amino acid from (r,s) amino acid or from keto acid
10/04/2007US20070228941 Amino compound for organic light-emitting device and organic light-emitting device including the same
10/04/2007DE102006015470A1 Substituierte Enaminocarbonylverbindungen Substituted enaminocarbonyl
10/04/2007DE102006015467A1 Substituierte Enaminocarbonylverbindungen Substituted enaminocarbonyl
10/04/2007CA2646732A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/04/2007CA2645487A1 1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases
10/04/2007CA2644369A1 Amide derivatives and their application for the treatment of g protein related diseases
10/04/2007CA2629836A1 Benzeneszkfibate salts and their use as intermediates for the synthesis of 2-[2-(1-alkyl-2-piperidyl)ethyl] cinnamanilides
10/03/2007EP1838696A1 Novel cyanoguanidine compounds
10/03/2007EP1838675A1 Novel 4-arylamino pyridone derivatives as mek inhibitors for the treatment of hyperproliferative disorders
10/03/2007EP1838674A2 Heteroaryl sulfonamides and ccr2
10/03/2007EP1838655A1 6-phenylhex-5-enoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
10/03/2007EP1599468B1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/03/2007EP1519932B1 Bisarylsulfonamide compounds and their use in cancer therapy
10/03/2007EP1307444B1 Substituted heterocyclic amides
10/03/2007EP1294378B1 Thrombopoietin mimetics
10/03/2007EP1183232B1 Monofluoroalkyl derivatives
10/03/2007CN101048380A Process for production of 2-hydroxy-4-substituted pyridines
10/03/2007CN101048375A Amino, amino acid or peptide conjugates of retinoic acid
10/03/2007CN101048374A Mercaptoamides as histone deacetylase inhibitors
10/03/2007CN101048368A Acyclic hydrazides as cannabinoid receptor modulators
10/03/2007CN101048367A New tyrosine derivative as ppar gamma regulator
10/03/2007CN101048157A Heterocyclic indanone potentiators of metabotropic glutamate receptors
10/03/2007CN101045706A 3-cyanopyridine absorption method
10/03/2007CN101045705A Preparation method of hydrated sodium phenolate trichloropyridine
10/03/2007CN100340548C Novel arylheteroalkylamine derivatives
10/03/2007CN100340545C Tetralone derivatives as antitumor agents
10/03/2007CN100340541C Process for preparation of alpha-hydroxycarboxylic acid amides
10/02/2007US7276726 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
10/02/2007US7276612 For hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides
10/02/2007US7276604 Stable in humid environments; bone resorption disorders; mixing and heating an aqueous solution of the salt hydrate with isopropanol and crystallizing during slow cooling
10/02/2007US7276528 Compounds for the inhibition of nitric oxide synthase
10/02/2007US7276523 For therapy and prophylaxis of postmenopausal osteoporosis, estrogen-dependent breast cancer, and cardiovascular disease
10/02/2007US7276518 For therapy of neuropathic or chronic pain
10/02/2007US7276500 Substituted amides, their preparation and use
10/02/2007CA2387357C Derivatives of pyrazolo[4,3-d]pyrimidin-7-ones which inhibit cyclic guanosine 3',5'-monophosphate phosphodiesterase
10/02/2007CA2096407C Retroviral protease inhibitors
09/2007
09/27/2007WO2007109459A2 Pyridines and pyridine n-oxides as modulators of thrombin
09/27/2007WO2007109175A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
09/27/2007WO2007108483A1 N-2-(hetero)arylethylcarboxamide derivative, and pest-controlling agent comprising the same
09/27/2007WO2007107594A2 Six-membered heterocycle substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors